FLGT Fulgent Genetics, Inc.
8-K Current Report
Filed: February 27, 2026
Health Care
Services-Medical LaboratoriesFulgent Genetics, Inc. (FLGT) 8-K current report filed with SEC EDGAR on February 27, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items2 items
- Item 2.02: Results of Operations and Financial Condition
- Item 7.01: Regulation FD Disclosure
AI Filing Analysis8-K
Item 2.02 · Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings released Feb 27, 2026 — details in Exhibit 99.1
- • Covers fiscal year ended Dec 31, 2025 — full annual results included alongside quarterly figures
Item 7.01 · Regulation FD Disclosure
- • Updated investor presentation published Feb 27, 2026, available on IR website and as Exhibit 99.2
- • Reg FD disclosure ensures material business updates reach all investors simultaneously — limits information asymmetry
Other Fulgent Genetics, Inc. 8-K Filings
Get deeper insights on Fulgent Genetics, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.